CAMP Stock Summary and Trading Ideas (Camp4 Therapeutics | NASDAQ:CAMP)

Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.

Camp4 Therapeutics trades on the NASDAQ stock market under the symbol CAMP.

As of December 19, 2025, CAMP stock price climbed to $6.38 with 1,762,050 million shares trading.

CAMP has a beta of 2.06, meaning it tends to be more sensitive to market movements. CAMP has a correlation of 0.05 to the broad based SPY ETF.

CAMP has a market cap of $299.10 million. This is considered a Small Cap stock.

Last quarter Camp4 Therapeutics reported $795,000 in Revenue and -$.55 earnings per share. This beat revenue expectation by $143,002 and missed earnings estimates by -$.07.

The top ETF exchange traded funds that CAMP belongs to (by Net Assets): VTI, VXF, IWC.

CAMP has outperformed the market in the last year with a price return of +19.5% while the SPY ETF gained +18.1%. CAMP has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +179.8% and +96.3%, respectively, while the SPY returned +2.8% and -0.5%, respectively.

CAMP support price is $5.45 and resistance is $6.97 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CAMP shares will trade within this expected range on the day.